Antiphospholipid antibodies testing and pregnancy outcomes in recurrent implantation failure women, is it necessary?
Active, not recruiting
- Conditions
- Recurrent implantation failure womenRecurrent implantation failureAntiphospholipid antibodiesICSI
- Registration Number
- TCTR20231003007
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- Female
- Target Recruitment
- 250
Inclusion Criteria
Women with recurrent implantation failure (more than 2 times)
Exclusion Criteria
Women with a history of thrombosis
Women diagnosed antiphospholipid syndrome
Women with uncorrected anatomical abnormalities
Women with uncontrolled autoimmune diseases
Women with uncontrolled endocrine disorders
Women who have an abnormal karyotype
Women who treated with anticaogulant
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pregnancy outcomes 5 years Percentage
- Secondary Outcome Measures
Name Time Method Factor associated with pregnancy outcomes 5 years factors,Incidence of aPL positive None Percentage